180 related articles for article (PubMed ID: 18792928)
1. A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes.
Wang MZ; Wu JQ; Dennison JB; Bridges AS; Hall SD; Kornbluth S; Tidwell RR; Smith PC; Voyksner RD; Paine MF; Hall JE
Proteomics; 2008 Oct; 8(20):4186-96. PubMed ID: 18792928
[TBL] [Abstract][Full Text] [Related]
2. Relative and absolute quantitative expression profiling of cytochromes P450 using isotope-coded affinity tags.
Jenkins RE; Kitteringham NR; Hunter CL; Webb S; Hunt TJ; Elsby R; Watson RB; Williams D; Pennington SR; Park BK
Proteomics; 2006 Mar; 6(6):1934-47. PubMed ID: 16479536
[TBL] [Abstract][Full Text] [Related]
3. Quantitative protein determination for CYP induction via LC-MS/MS.
Williamson BL; Purkayastha S; Hunter CL; Nuwaysir L; Hill J; Easterwood L; Hill J
Proteomics; 2011 Jan; 11(1):33-41. PubMed ID: 21182192
[TBL] [Abstract][Full Text] [Related]
4. Application of slicing of one-dimensional gels with subsequent slice-by-slice mass spectrometry for the proteomic profiling of human liver cytochromes P450.
Lisitsa AV; Petushkova NA; Thiele H; Moshkovskii SA; Zgoda VG; Karuzina II; Chernobrovkin AL; Skipenko OG; Archakov AI
J Proteome Res; 2010 Jan; 9(1):95-103. PubMed ID: 19722723
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry-based proteomic analysis of human liver cytochrome(s) P450.
Shrivas K; Mindaye ST; Getie-Kebtie M; Alterman MA
Toxicol Appl Pharmacol; 2013 Feb; 267(1):125-36. PubMed ID: 23274569
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of cytochrome p450 isozymes by means of unique isozyme-specific tryptic peptides: a proteomic approach.
Alterman MA; Kornilayev B; Duzhak T; Yakovlev D
Drug Metab Dispos; 2005 Sep; 33(9):1399-407. PubMed ID: 15951447
[TBL] [Abstract][Full Text] [Related]
7. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry.
Redlich G; Zanger UM; Riedmaier S; Bache N; Giessing AB; Eisenacher M; Stephan C; Meyer HE; Jensen ON; Marcus K
J Proteome Res; 2008 Nov; 7(11):4678-88. PubMed ID: 18828626
[TBL] [Abstract][Full Text] [Related]
8. Thin-layer chromatography analysis of human CYP3A-catalyzed testosterone 6beta-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():133-41. PubMed ID: 16719384
[TBL] [Abstract][Full Text] [Related]
9. A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionization-tandem mass spectrometry.
Nisar S; Lane CS; Wilderspin AF; Welham KJ; Griffiths WJ; Patterson LH
Drug Metab Dispos; 2004 Apr; 32(4):382-6. PubMed ID: 15039290
[TBL] [Abstract][Full Text] [Related]
10. A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.
Hashizume T; Mise M; Matsumoto S; Terauchi Y; Fujii T; Imaoka S; Funae Y; Kamataki T; Miyazaki H
Drug Metab Dispos; 2001 Jun; 29(6):798-805. PubMed ID: 11353747
[TBL] [Abstract][Full Text] [Related]
11. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
Isoherranen N; Ludington SR; Givens RC; Lamba JK; Pusek SN; Dees EC; Blough DK; Iwanaga K; Hawke RL; Schuetz EG; Watkins PB; Thummel KE; Paine MF
Drug Metab Dispos; 2008 Jan; 36(1):146-54. PubMed ID: 17954524
[TBL] [Abstract][Full Text] [Related]
12. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.
Snawder JE; Lipscomb JC
Regul Toxicol Pharmacol; 2000 Oct; 32(2):200-9. PubMed ID: 11067776
[TBL] [Abstract][Full Text] [Related]
13. Absolute quantification strategies in proteomics based on mass spectrometry.
Brönstrup M
Expert Rev Proteomics; 2004 Dec; 1(4):503-12. PubMed ID: 15966845
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of cytochrome P450 isoforms in human liver microsomes by the combination of proteomics and chemical probe-based assay.
Liu X; Hu L; Ge G; Yang B; Ning J; Sun S; Yang L; Pors K; Gu J
Proteomics; 2014 Aug; 14(16):1943-51. PubMed ID: 24920405
[TBL] [Abstract][Full Text] [Related]
15. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
16. The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.
Michaels S; Wang MZ
Drug Metab Dispos; 2014 Aug; 42(8):1241-51. PubMed ID: 24816681
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
Achour B; Russell MR; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
[TBL] [Abstract][Full Text] [Related]
18. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
19. Utility of polyclonal antibodies targeted toward unique tryptic peptides in the proteomic analysis of cytochrome P450 isozymes.
Kornilayev BA; Alterman MA
Toxicol In Vitro; 2008 Apr; 22(3):779-87. PubMed ID: 18207356
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches.
Petushkova NA; Kanaeva IP; Lisitsa AV; Sheremetyeva GF; Zgoda VG; Samenkova NF; Karuzina II; Archakov AI
Toxicol In Vitro; 2006 Sep; 20(6):966-74. PubMed ID: 16533590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
